Loading…

Attitudes of people with inherited retinal conditions toward gene editing technology

Background The views of people with genetic conditions are crucial to include in public dialogue around developing gene editing technologies. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amauro...

Full description

Saved in:
Bibliographic Details
Published in:Molecular genetics & genomic medicine 2019-07, Vol.7 (7), p.e00803-n/a
Main Authors: Hoffman‐Andrews, Lily, Mazzoni, Ronit, Pacione, Michelle, Garland‐Thomson, Rosemarie, Ormond, Kelly E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5043-eb0170f0c88b873a3161732f1f98ddf6df66b940e45c393e14e32701395d48653
cites cdi_FETCH-LOGICAL-c5043-eb0170f0c88b873a3161732f1f98ddf6df66b940e45c393e14e32701395d48653
container_end_page n/a
container_issue 7
container_start_page e00803
container_title Molecular genetics & genomic medicine
container_volume 7
creator Hoffman‐Andrews, Lily
Mazzoni, Ronit
Pacione, Michelle
Garland‐Thomson, Rosemarie
Ormond, Kelly E.
description Background The views of people with genetic conditions are crucial to include in public dialogue around developing gene editing technologies. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing. Methods Individuals with RP (N = 9) and LCA (N = 8) participated in semi‐structured qualitative interviews about their experience with and attitudes toward blindness, and their views about gene editing technology for somatic, germline, and enhancement applications. Results Participants saw potential benefits from gene editing in general, but views about its use for retinal conditions varied and were influenced by personal perspectives on blindness. Those who felt more negatively toward blindness, particularly those with later onset blindness, were more supportive of gene editing for retinal conditions. Concerns about both germline and somatic editing included: the importance of informed consent; impacts of gene editing on social attitudes and barriers affecting blind people; and worries about “eliminating” blindness or other traits. Conclusion People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing for these conditions. People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them.
doi_str_mv 10.1002/mgg3.803
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_22ecd9344ed74015bc8e249da15f0e4b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_22ecd9344ed74015bc8e249da15f0e4b</doaj_id><sourcerecordid>2256035316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5043-eb0170f0c88b873a3161732f1f98ddf6df66b940e45c393e14e32701395d48653</originalsourceid><addsrcrecordid>eNp1kV1rHCEYRqW0NGEb6C8oQm96M6lf48zcFEJIt4GU3qTX4ug7sy6zulWny_77uh8NSaEiKHo4Pvgg9J6Sa0oI-7wZR37dEv4KXTLORNUx2b1-tr9AVymtSRltK6hs3qILTmlHREMv0eNNzi7PFhIOA95C2E6Ady6vsPMriC6DxRGy83rCJnjrsgs-4Rx2Olo8ggcMh0M_4gxm5cMUxv079GbQU4Kr87pAP7_ePd5-qx5-LO9vbx4qUxPBK-gJbchATNv2bcM1p5I2nA106FprB1mm7DtBQNSGdxyoAM4aQnlXW9HKmi_Q_clrg16rbXQbHfcqaKeOByGOSsfszASKMTC240KAbQShdW9aYKKzmtZDeaAvri8n13buN2AN-Bz19EL68sa7lRrDbyUlq0mJv0CfzoIYfs2Qstq4ZGCatIcwp5KgbhraSSoL-vEfdB3mWL74SEnCa36kzkITQ0oRhqcwlKhD8-rQvCrNF_TD8_BP4N-eC1CdgJ2bYP9fkfq-XPKD8A_Iabbd</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2256035316</pqid></control><display><type>article</type><title>Attitudes of people with inherited retinal conditions toward gene editing technology</title><source>Open Access: PubMed Central</source><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content Database</source><creator>Hoffman‐Andrews, Lily ; Mazzoni, Ronit ; Pacione, Michelle ; Garland‐Thomson, Rosemarie ; Ormond, Kelly E.</creator><creatorcontrib>Hoffman‐Andrews, Lily ; Mazzoni, Ronit ; Pacione, Michelle ; Garland‐Thomson, Rosemarie ; Ormond, Kelly E.</creatorcontrib><description>Background The views of people with genetic conditions are crucial to include in public dialogue around developing gene editing technologies. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing. Methods Individuals with RP (N = 9) and LCA (N = 8) participated in semi‐structured qualitative interviews about their experience with and attitudes toward blindness, and their views about gene editing technology for somatic, germline, and enhancement applications. Results Participants saw potential benefits from gene editing in general, but views about its use for retinal conditions varied and were influenced by personal perspectives on blindness. Those who felt more negatively toward blindness, particularly those with later onset blindness, were more supportive of gene editing for retinal conditions. Concerns about both germline and somatic editing included: the importance of informed consent; impacts of gene editing on social attitudes and barriers affecting blind people; and worries about “eliminating” blindness or other traits. Conclusion People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing for these conditions. People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them.</description><identifier>ISSN: 2324-9269</identifier><identifier>EISSN: 2324-9269</identifier><identifier>DOI: 10.1002/mgg3.803</identifier><identifier>PMID: 31190471</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Aged ; Attitude ; Attitude to Health ; Attitudes ; Bioethics ; Blind people ; Blindness ; Blindness - congenital ; Blindness - genetics ; Clinical trials ; CRISPR ; Deafness ; Disability ; Ethics ; Female ; gene editing ; Gene Editing - ethics ; Gene therapy ; Genetic counseling ; Genetic modification ; Genotype ; Health Knowledge, Attitudes, Practice ; Humans ; Informed consent ; Leber congenital amaurosis ; Leber Congenital Amaurosis - genetics ; Leber Congenital Amaurosis - psychology ; Male ; Middle Aged ; Mutation ; Original ; Pedigree ; People with disabilities ; Phenotype ; Qualitative analysis ; Qualitative research ; Retina ; Retinal Diseases - genetics ; Retinal Diseases - psychology ; Retinitis ; Retinitis pigmentosa ; Retinitis Pigmentosa - genetics ; Retinitis Pigmentosa - psychology ; Social attitudes ; Technology ; United States</subject><ispartof>Molecular genetics &amp; genomic medicine, 2019-07, Vol.7 (7), p.e00803-n/a</ispartof><rights>2019 The Authors. published by Wiley Periodicals, Inc.</rights><rights>2019 The Authors. Molecular Genetics &amp; Genomic Medicine published by Wiley Periodicals, Inc.</rights><rights>Copyright John Wiley &amp; Sons, Inc. Jul 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5043-eb0170f0c88b873a3161732f1f98ddf6df66b940e45c393e14e32701395d48653</citedby><cites>FETCH-LOGICAL-c5043-eb0170f0c88b873a3161732f1f98ddf6df66b940e45c393e14e32701395d48653</cites><orcidid>0000-0001-8021-8306 ; 0000-0003-3999-6012 ; 0000-0003-2844-1855 ; 0000-0002-1033-0818</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2256035316/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2256035316?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11540,25730,27900,27901,36988,36989,44565,46026,46450,53765,53767,75095</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31190471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoffman‐Andrews, Lily</creatorcontrib><creatorcontrib>Mazzoni, Ronit</creatorcontrib><creatorcontrib>Pacione, Michelle</creatorcontrib><creatorcontrib>Garland‐Thomson, Rosemarie</creatorcontrib><creatorcontrib>Ormond, Kelly E.</creatorcontrib><title>Attitudes of people with inherited retinal conditions toward gene editing technology</title><title>Molecular genetics &amp; genomic medicine</title><addtitle>Mol Genet Genomic Med</addtitle><description>Background The views of people with genetic conditions are crucial to include in public dialogue around developing gene editing technologies. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing. Methods Individuals with RP (N = 9) and LCA (N = 8) participated in semi‐structured qualitative interviews about their experience with and attitudes toward blindness, and their views about gene editing technology for somatic, germline, and enhancement applications. Results Participants saw potential benefits from gene editing in general, but views about its use for retinal conditions varied and were influenced by personal perspectives on blindness. Those who felt more negatively toward blindness, particularly those with later onset blindness, were more supportive of gene editing for retinal conditions. Concerns about both germline and somatic editing included: the importance of informed consent; impacts of gene editing on social attitudes and barriers affecting blind people; and worries about “eliminating” blindness or other traits. Conclusion People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing for these conditions. People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them.</description><subject>Adult</subject><subject>Aged</subject><subject>Attitude</subject><subject>Attitude to Health</subject><subject>Attitudes</subject><subject>Bioethics</subject><subject>Blind people</subject><subject>Blindness</subject><subject>Blindness - congenital</subject><subject>Blindness - genetics</subject><subject>Clinical trials</subject><subject>CRISPR</subject><subject>Deafness</subject><subject>Disability</subject><subject>Ethics</subject><subject>Female</subject><subject>gene editing</subject><subject>Gene Editing - ethics</subject><subject>Gene therapy</subject><subject>Genetic counseling</subject><subject>Genetic modification</subject><subject>Genotype</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>Informed consent</subject><subject>Leber congenital amaurosis</subject><subject>Leber Congenital Amaurosis - genetics</subject><subject>Leber Congenital Amaurosis - psychology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Original</subject><subject>Pedigree</subject><subject>People with disabilities</subject><subject>Phenotype</subject><subject>Qualitative analysis</subject><subject>Qualitative research</subject><subject>Retina</subject><subject>Retinal Diseases - genetics</subject><subject>Retinal Diseases - psychology</subject><subject>Retinitis</subject><subject>Retinitis pigmentosa</subject><subject>Retinitis Pigmentosa - genetics</subject><subject>Retinitis Pigmentosa - psychology</subject><subject>Social attitudes</subject><subject>Technology</subject><subject>United States</subject><issn>2324-9269</issn><issn>2324-9269</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kV1rHCEYRqW0NGEb6C8oQm96M6lf48zcFEJIt4GU3qTX4ug7sy6zulWny_77uh8NSaEiKHo4Pvgg9J6Sa0oI-7wZR37dEv4KXTLORNUx2b1-tr9AVymtSRltK6hs3qILTmlHREMv0eNNzi7PFhIOA95C2E6Ady6vsPMriC6DxRGy83rCJnjrsgs-4Rx2Olo8ggcMh0M_4gxm5cMUxv079GbQU4Kr87pAP7_ePd5-qx5-LO9vbx4qUxPBK-gJbchATNv2bcM1p5I2nA106FprB1mm7DtBQNSGdxyoAM4aQnlXW9HKmi_Q_clrg16rbXQbHfcqaKeOByGOSsfszASKMTC240KAbQShdW9aYKKzmtZDeaAvri8n13buN2AN-Bz19EL68sa7lRrDbyUlq0mJv0CfzoIYfs2Qstq4ZGCatIcwp5KgbhraSSoL-vEfdB3mWL74SEnCa36kzkITQ0oRhqcwlKhD8-rQvCrNF_TD8_BP4N-eC1CdgJ2bYP9fkfq-XPKD8A_Iabbd</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Hoffman‐Andrews, Lily</creator><creator>Mazzoni, Ronit</creator><creator>Pacione, Michelle</creator><creator>Garland‐Thomson, Rosemarie</creator><creator>Ormond, Kelly E.</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8021-8306</orcidid><orcidid>https://orcid.org/0000-0003-3999-6012</orcidid><orcidid>https://orcid.org/0000-0003-2844-1855</orcidid><orcidid>https://orcid.org/0000-0002-1033-0818</orcidid></search><sort><creationdate>201907</creationdate><title>Attitudes of people with inherited retinal conditions toward gene editing technology</title><author>Hoffman‐Andrews, Lily ; Mazzoni, Ronit ; Pacione, Michelle ; Garland‐Thomson, Rosemarie ; Ormond, Kelly E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5043-eb0170f0c88b873a3161732f1f98ddf6df66b940e45c393e14e32701395d48653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Attitude</topic><topic>Attitude to Health</topic><topic>Attitudes</topic><topic>Bioethics</topic><topic>Blind people</topic><topic>Blindness</topic><topic>Blindness - congenital</topic><topic>Blindness - genetics</topic><topic>Clinical trials</topic><topic>CRISPR</topic><topic>Deafness</topic><topic>Disability</topic><topic>Ethics</topic><topic>Female</topic><topic>gene editing</topic><topic>Gene Editing - ethics</topic><topic>Gene therapy</topic><topic>Genetic counseling</topic><topic>Genetic modification</topic><topic>Genotype</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>Informed consent</topic><topic>Leber congenital amaurosis</topic><topic>Leber Congenital Amaurosis - genetics</topic><topic>Leber Congenital Amaurosis - psychology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Original</topic><topic>Pedigree</topic><topic>People with disabilities</topic><topic>Phenotype</topic><topic>Qualitative analysis</topic><topic>Qualitative research</topic><topic>Retina</topic><topic>Retinal Diseases - genetics</topic><topic>Retinal Diseases - psychology</topic><topic>Retinitis</topic><topic>Retinitis pigmentosa</topic><topic>Retinitis Pigmentosa - genetics</topic><topic>Retinitis Pigmentosa - psychology</topic><topic>Social attitudes</topic><topic>Technology</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoffman‐Andrews, Lily</creatorcontrib><creatorcontrib>Mazzoni, Ronit</creatorcontrib><creatorcontrib>Pacione, Michelle</creatorcontrib><creatorcontrib>Garland‐Thomson, Rosemarie</creatorcontrib><creatorcontrib>Ormond, Kelly E.</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecular genetics &amp; genomic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoffman‐Andrews, Lily</au><au>Mazzoni, Ronit</au><au>Pacione, Michelle</au><au>Garland‐Thomson, Rosemarie</au><au>Ormond, Kelly E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attitudes of people with inherited retinal conditions toward gene editing technology</atitle><jtitle>Molecular genetics &amp; genomic medicine</jtitle><addtitle>Mol Genet Genomic Med</addtitle><date>2019-07</date><risdate>2019</risdate><volume>7</volume><issue>7</issue><spage>e00803</spage><epage>n/a</epage><pages>e00803-n/a</pages><issn>2324-9269</issn><eissn>2324-9269</eissn><abstract>Background The views of people with genetic conditions are crucial to include in public dialogue around developing gene editing technologies. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing. Methods Individuals with RP (N = 9) and LCA (N = 8) participated in semi‐structured qualitative interviews about their experience with and attitudes toward blindness, and their views about gene editing technology for somatic, germline, and enhancement applications. Results Participants saw potential benefits from gene editing in general, but views about its use for retinal conditions varied and were influenced by personal perspectives on blindness. Those who felt more negatively toward blindness, particularly those with later onset blindness, were more supportive of gene editing for retinal conditions. Concerns about both germline and somatic editing included: the importance of informed consent; impacts of gene editing on social attitudes and barriers affecting blind people; and worries about “eliminating” blindness or other traits. Conclusion People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing for these conditions. People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>31190471</pmid><doi>10.1002/mgg3.803</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-8021-8306</orcidid><orcidid>https://orcid.org/0000-0003-3999-6012</orcidid><orcidid>https://orcid.org/0000-0003-2844-1855</orcidid><orcidid>https://orcid.org/0000-0002-1033-0818</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2324-9269
ispartof Molecular genetics & genomic medicine, 2019-07, Vol.7 (7), p.e00803-n/a
issn 2324-9269
2324-9269
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_22ecd9344ed74015bc8e249da15f0e4b
source Open Access: PubMed Central; Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content Database
subjects Adult
Aged
Attitude
Attitude to Health
Attitudes
Bioethics
Blind people
Blindness
Blindness - congenital
Blindness - genetics
Clinical trials
CRISPR
Deafness
Disability
Ethics
Female
gene editing
Gene Editing - ethics
Gene therapy
Genetic counseling
Genetic modification
Genotype
Health Knowledge, Attitudes, Practice
Humans
Informed consent
Leber congenital amaurosis
Leber Congenital Amaurosis - genetics
Leber Congenital Amaurosis - psychology
Male
Middle Aged
Mutation
Original
Pedigree
People with disabilities
Phenotype
Qualitative analysis
Qualitative research
Retina
Retinal Diseases - genetics
Retinal Diseases - psychology
Retinitis
Retinitis pigmentosa
Retinitis Pigmentosa - genetics
Retinitis Pigmentosa - psychology
Social attitudes
Technology
United States
title Attitudes of people with inherited retinal conditions toward gene editing technology
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T08%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attitudes%20of%20people%20with%20inherited%20retinal%20conditions%20toward%20gene%20editing%20technology&rft.jtitle=Molecular%20genetics%20&%20genomic%20medicine&rft.au=Hoffman%E2%80%90Andrews,%20Lily&rft.date=2019-07&rft.volume=7&rft.issue=7&rft.spage=e00803&rft.epage=n/a&rft.pages=e00803-n/a&rft.issn=2324-9269&rft.eissn=2324-9269&rft_id=info:doi/10.1002/mgg3.803&rft_dat=%3Cproquest_doaj_%3E2256035316%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5043-eb0170f0c88b873a3161732f1f98ddf6df66b940e45c393e14e32701395d48653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2256035316&rft_id=info:pmid/31190471&rfr_iscdi=true